Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solon Eiendom ASA : Primary insider notification


Posted on: 22 Jan 18

(Oslo, Norway, 21 March 2018) Per Knut Asphaug Bernhardt, personal assistant to the chairman of the board of Solon Eiendom ASA, (through his wholly owned company Factum AS) has today rolled over a forward contract for 74,375 shares in Solon Eiendom ASA. The new contract expires on 27 August 2018 at a strike price of NOK 18.81 per share.

Per Knut Asphaug Bernhardt, directly and through his wholly owned company Factum AS, holds forward contracts for a total of 124,375 shares, equaling 0.233 % of the total share capital and votes of the Company.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.
Further information
Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
E-mail: am@soloneiendom.no Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
E-mail: sd@soloneiendom.no Cell Phone: +47 952 55 620

About Solon Eiendom
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region.

Attachment:

http://www.globenewswire.com/NewsRoom/AttachmentNg/d210c21d-79ee-4c4d-b0f6-5ab7f7a35d8b

GlobeNewswire
globenewswire.com

Last updated on: 22/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.